ArticleCatheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions2026
Transcatheter Tricuspid Valve Replacement for Residual Tricuspid Regurgitation After TEER.
Article in Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Transcatheter Tricuspid Valve Replacement for Residual Tricuspid Regurgitation After TEER.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundResidual or recurrent tricuspid regurgitation (TR) after prior transcatheter tricuspid edge-to-edge (T-TEER) repair occurs in about 12% of patients within 1 year. Since surgical tricuspid valve repair or replacement is of high risk, treatment options remain scarce. Data regarding the feasibility, safety, and treatment strategies using transcatheter valve replacement (TTVR) after T-TEER are sparse.
aimsHere, we aimed to summarize our early experience in TTVR after failed T-TEER, analyze its feasibility and summarize the results in a distinct algorithm.
methodsPatients undergoing TTVR (n = 21) at the University Hospital of Duesseldorf were prospectively analyzed and stratified according prior T-TEER procedures with implanted devices. Groups were compared in terms of procedural success, periprocedural complications, and patient outcomes. Individual treatment decisions for patients after T-TEER were analyzed.
resultsFive patients had residual/recurrent severe to torrential TR and underwent TTVR after T-TEER, whereas 16 patients were primarily referred for TTVR. Preprocedural wire-based intentional clip excision (WICE) was performed in 60% of these patients. Patients did not differ regarding procedural success (100% in both groups, p = 0.99) and periprocedural complications (0 [TTVR after TEER] vs. 5.6% [primary TTVR], p = 0.99 for the combined endpoint of in-hospital death, stroke, myocardial infarction, re-intervention or surgery, and major bleeding). A pacemaker was required in one patient of each group, p = 0.4). Procedural times were higher among patients with prior T-TEER. Treatment decisions for patients after T-TEER were integrated into a treatment algorithm.
conclusionThe valve after clip concept is feasible and the proposed algorithm may support procedural planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.